Radiology Oncology Systems, Inc.

Radiology Oncology Systems, Inc. is a US-based company specializing in refurbished medical equipment, focusing on radiation therapy and diagnostic imaging solutions for healthcare providers worldwide. Radiology Oncology Systems (ROS) was founded in 1997 in San Diego, US. The company provides refurbished medical equipment and has not publicly reported any significant pivots.

ROS operates independently and has not disclosed any parent companies or subsidiaries. The company's founder has a history of involvement in healthcare-related initiatives, although specific details of prior ventures are not available. Radiology Oncology Systems (ROS) specializes in providing high-quality refurbished medical equipment, primarily focusing on radiation therapy and diagnostic imaging solutions. Their main product offerings include refurbished linear accelerators, CT scanners, MRI systems, PET/CT scanners, and CT simulators, all designed to enhance the accessibility and affordability of healthcare services.

These products are utilized by hospitals, outpatient centers, academic institutions, and specialty practices, enabling healthcare providers to deliver precise diagnostic and treatment options to patients. ROS’s equipment operates under rigorous quality standards, ensuring compliance with original equipment manufacturer (OEM) specifications. The company has a global reach, serving clients in over 67 countries, including North America, Europe, Asia, and South America, thereby facilitating improved healthcare delivery on an international scale. The revenue structure of Radiology Oncology Systems is primarily driven by the sale of refurbished medical equipment and associated services, which include installation, training, and after-sales support.

Transactions within the business typically occur on a B2B basis, where healthcare facilities engage directly with ROS to purchase equipment tailored to their specific needs. The company’s flagship offerings, such as the Varian TrueBeam linear accelerator and GE Discovery PET/CT scanner, are integral to their sales strategy. Clients may enter into contracts that encompass both the purchase of equipment and ongoing service agreements to ensure optimal performance and maintenance. Pricing plans are structured around individual product offerings and service packages, allowing clients to select options that align with their operational requirements and budget considerations.

Radiology Oncology Systems has plans to expand its product line to include advanced radiation therapy technologies and enhanced diagnostic imaging solutions, with potential product launches slated for the next 18 months. Additionally, the company targets expansion into emerging markets in Asia and South America by the end of 2025. Recent funding will be strategically utilized to support these product developments and market entry initiatives.